Clinical Trial Results:
A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 52 Weeks Treatment with LAF237 50 mg qd to Placebo in Drug-Naïve Patients with Type 2 Diabetes and Mild Hyperglycemia
Summary
|
|
EudraCT number |
2004-000539-27 |
Trial protocol |
SE FI ES |
Global completion date |
26 Jun 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
09 Oct 2016
|
First version publication date |
09 Oct 2016
|
Other versions |
|
Summary report(s) |
CLAF237A2307_CLAF237A2307E1_NovCTR_15Mar2018 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.